| Product name | Amino Tadalafil |
| Other name | (6R,12aR)-2-Amino-6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione;AminoTadalafil(6R,12Ar)-2-Amino-6-(1,3-Benzodioxol-5-Yl)-2,3,6,7,12,12A-Hexahydropyrazino[1',2':1,6]Pyrido[3,4-B]Indole-1,4-Dione;(6R,12aR)-2-Amino-6-(benzo[d][1,3]dioxol-5-yl)-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indol-1,4-dione;(6R,12aR)-2-amino-6-(benzo[d][1,3]dioxol-5-yl)-2,3,12,12a-tetrahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4(6H,7H)-dione |
| CAS No. | 385769-84-6 |
| Molecular formula | C21H18N4O4 |
| Molecular weight | 390.39 |
| Purity | 98.0% |
| Appearance | White to off-white powder |
| Application | Dietary Supplement Raw Material |
Amino Tadalafil is a compound similar to Tadalafil, with some of the functional groups in its structure being replaced by amino groups. It is a PDE5 inhibitor and has pharmacological effects similar to Tadalafil. It is mainly used for the treatment of male erectile dysfunction (ED). Compared to Tadalafil, Amino Tadalafil has a slower metabolic rate in the body, and thus may have a longer-lasting effect.Amino Tadalafil is a compound developed in recent years, which has a structure similar to Tadalafil, but some groups in its structure are replaced by amino groups. Currently, Amino Tadalafil has not been approved for medical use, so its application in the medical field is relatively limited. However, some studies have shown that this compound has great potential for application. Amino Tadalafil is a PDE5 inhibitor, which has a similar pharmacological effect as Tadalafil. It can improve the symptoms of erectile dysfunction (ED) by promoting blood flow in the male reproductive organs by blocking the activity of the PDE5 enzyme. Compared with Tadalafil, Amino Tadalafil has a slower metabolism rate in the body, which may have a more lasting effect. This makes Amino Tadalafil have great potential in the treatment of ED. In addition, Amino Tadalafil can also be used to treat some other diseases, such as pulmonary arterial hypertension. Some studies have shown that PDE5 inhibitors can dilate pulmonary blood vessels, thereby improving the symptoms of patients with pulmonary arterial hypertension. Because Amino Tadalafil has a similar pharmacological effect as Tadalafil, it may also be used to treat pulmonary arterial hypertension. Overall, Amino Tadalafil has great application potential, but more clinical trials are needed to determine its safety and efficacy. If these trials yield positive results, Amino Tadalafil may become a new drug for the treatment of ED and pulmonary arterial hypertension, providing more treatment options for clinical doctors and patients.
(3)Fewer side effects: Amino Tadalafil has fewer side effects compared to Tadalafil, such as headaches, and gastrointestinal discomfort. Due to its higher selectivity, Amino Tadalafil can more effectively avoid interactions with other PDE subtypes, reducing the incidence of side effects. (4)Wide application prospects: In addition to treating ED, Amino Tadalafil may also be used to treat other diseases such as pulmonary arterial hypertension. This makes Amino Tadalafil have broad application prospects in the future.(1)High selectivity: Amino Tadalafil has high selectivity for PDE5, with a significantly higher affinity for PDE5 than other PDE subtypes. This means that Amino Tadalafil can more effectively block the activity of the PDE5 enzyme, promoting blood flow in the male reproductive organs and improving the symptoms of erectile dysfunction (ED). (2)Long-lasting effect: Amino Tadalafil has a slower metabolism rate in the body, which allows it to produce a more prolonged pharmacological effect, lasting up to 36 hours. This makes Amino Tadalafil a long-acting ED treatment drug, which does not need to be taken frequently.
